Skip to content

EPS (Diluted) at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$2.14-52.9%
Stryker logo
StrykerSYK
$1.93+14.2%
Alphatec Holdings logo
Alphatec HoldingsATEC
-$0.22+37.1%
Enovis logo
EnovisENOV
-$0.15+84.7%
Medtronic logo
MedtronicMDT
$0.97+18.3%
Bioventus logo
BioventusBVS
$0.04+200%

Other financials

Income statement

See full
Revenue$196.7M+1.6%
Gross profit$139.5M+14.7%
Operating income-$14.4M+70.5%
Net income-$20.9M+60.6%

Balance sheet

See full
Cash & equivalents$120.3M+108%
Total debt$237.5M+32.3%
Total equity$435.2M-5.0%
Total assets$886.6M+7.7%

Cash flow

See full
Operating cash flow-$17.6M+4.2%
CapEx$10.7M+58.3%
Free cash flow-$28.3M-12.5%

Valuation

See full
Market cap$376.33M-7.1%
Enterprise value$493.54M-6.3%
P/S0.5×0.0×

Profitability

See full
Gross margin70.7%+3.6pp
Operating margin-5.8%-2.1pp
Net margin-7.3%-2.7pp
FCF margin-9.3%-1.7pp

Returns & leverage

See full
Return on equity-13.4%-4.6pp
Debt / equity0.5×+0.2×
Current ratio2.9×+0.2×

Where this comes from

Reported directly by Orthofix Medical Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Orthofix Medical Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Orthofix Medical Inc.'s eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Orthofix Medical Inc.'s EPS (diluted)?
Orthofix Medical Inc. (OFIX) reported EPS (diluted) of -$0.52 in Q1 2026.
How has Orthofix Medical Inc.'s EPS (diluted) changed year-over-year?
Orthofix Medical Inc.'s EPS (diluted) increased by 61.5% year-over-year, from -$1.35 to -$0.52.
What is the long-term trend for Orthofix Medical Inc.'s EPS (diluted)?
Over 4 years (2021 to 2025), Orthofix Medical Inc.'s EPS (diluted) has grown at a 7.6% compound annual growth rate (CAGR), from -$1.74 to -$2.33.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.